Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$223K Buy
795
+9
+1% +$2.37K 0.06% 258
2026
Q1
$210K Sell
786
-176
-18% -$47.7K 0.07% 253
2025
Q4
$241K Sell
962
-38
-4% -$10.1K 0.08% 228
2025
Q3
$287K Sell
1,000
-41
-4% -$11K 0.1% 189
2025
Q2
$273K Sell
1,041
-62
-6% -$15.1K 0.11% 177
2025
Q1
$257K Sell
1,103
-11
-1% -$2.67K 0.14% 136
2024
Q4
$255K Sell
1,114
-34
-3% -$7.8K 0.13% 145
2024
Q3
$256K Buy
1,148
+27
+2% +$5.93K 0.21% 124
2024
Q2
$228K Buy
1,121
+12
+1% +$2.44K 0.15% 131
2024
Q1
$242K Sell
1,109
-1
-0.1% -$220 0.27% 111
2023
Q4
$252K Buy
+1,110
New +$233K 0.32% 100

Other funds holding LH

Sunpointe's LH Position: Q2 2026 in Review

Sunpointe increased its Labcorp (LH) stake by 1.1% in Q2 2026, buying an estimated $2.37K and bringing the position to 795 shares worth $223K. The position accounts for 0.06% of the portfolio, ranked #258.

Sunpointe first reported a position in LH in Q4 2023 and has held it in 11 quarters since. The position peaked at $287K in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Sunpointe held 795 shares of Labcorp worth $223K as of Q2 2026.
  • Sunpointe bought 9 Labcorp shares in Q2 2026, an estimated $2.37K.
  • Labcorp made up 0.06% of Sunpointe's portfolio in Q2 2026, its #258 holding.
  • Sunpointe first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
  • Sunpointe's Labcorp position peaked at $287K in Q3 2025.
  • 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Sunpointe's 13F filing for Q2 2026, filed 24 Jul 2026.